A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis

A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis

Abstract The outcome of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is only favorable in ≈ 40% of acute ischemic stroke (AIS) patients. Moreover, in ≈ 6–8% of cases, intracerebral hemorrhage (ICH) develops. We tested whether a modification of clot lysis assay (CLA...

Full description

Bibliographic Details
Main Authors: Rita Orbán-Kálmándi, István Szegedi, Ferenc Sarkady, István Fekete, Klára Fekete, Nikolett Vasas, Ervin Berényi, László Csiba, Zsuzsa Bagoly
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-92041-1

Internet

https://doi.org/10.1038/s41598-021-92041-1

Similar Items